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 14 
Influenza A virus (IAV) is an enveloped virus of the Orthomyxoviridae with a negative-sense 15 
single-stranded RNA genome. During virus cell entry, viral and cellular cues are delivered in a 16 
stepwise manner within two distinct cellular compartments – the endosomes and the cytosol. 17 
Endosome maturation primes the viral core for uncoating by cytosolic host proteins and host-18 
mediated virus disaggregation is essential for genome import and replication in the nucleus. 19 
Recent evidence shows that two well-known cellular proteins - histone deacetylase 6 (HDAC6) 20 
and karyopherin-ββ2 (kKapββ2) - uncoat influenza virus. HDAC6 is one of eleven HDACs and 21 
an X-linked, cytosolic lysine deacetylase. Under normal cellular conditions HDAC6 is the tubulin 22 
deacetylase. Under proteasomal stress HDAC6 binds unanchored ubiquitin, dynein and myosin II 23 
to sequester misfolded protein aggregates for autophagy. Kapββ2 is a member of the importin β24 
β family that transports RNA-binding proteins into the nucleus by binding to disordered nuclear 25 
localization signals (NLSs) known as PY-NLS. Kapββ2 is emerging as a universal uncoating factor 26 
for IAV and human immunodeficiency virus type 1 (HIV-1). Kapβ2 can also reverse liquid-27 
liquid phase separation (LLPS) of RNA-binding proteins by promoting their disaggregation. Thus, 28 
it is becoming evident that key players in the management of cellular condensates and 29 
membraneless organelles are potent virus uncoating factors. This emerging concept reveals 30 
implications in viral pathogenesis, as well as, the promise for cell-targeted therapeutic strategies 31 
to block universal virus uncoating pathways hijacked by enveloped RNA viruses.  32 
 33 
Fundamentals of IAV entry 34 
 35 
Influenza virus is an enveloped virus with a negative-sense single-stranded RNA genome. As 36 
shown in Figure 1, two viral glycoproteins decorate the viral membrane surface; the fusion 37 
protein and receptor-binding hemagglutinin (HA) and neuraminidase (NA). Inside the viral 38 
membrane is the viral capsid made of matrix protein (M1), inside which the eight segments of 39 
viral ribonucleoproteins (vRNPs) are encapsidated. Each RNP contains the RNA genome, and the 40 
viral polymerase. IAV undergoes a series of stepwise uncoating events during cell entry as the 41 
virus particle is assisted by facilitators and a complex set of temporally and spatially regulated 42 
cellular cues (Yamauchi and Greber, 2016). Entry begins with multivalent attachment of the viral 43 
HA to sialic acid containing cell surface receptors (Skehel and Wiley, 2000). The half-life of HA-44 
sialic acid binding is 0.8–5.5 sec (Sieben et al., 2012), whereas that of IAV internalisation is 10–15  45 
min (Matlin et al., 1981). Thus, multivalent binding of HA to sialic acid-containing molecules 46 
such as epidermal growth factor receptor (EGFR) is necessary to trigger signalling and uptake of 47 
the viral particle into early endosomes via receptor-mediated endocytosis (Eierhoff et al., 2010). 48 
More recently it was shown that IAV infection activates G coupled protein receptor kinase 2 49 
(GRK2) which promotes downstream viral uncoating (Yanguez et al., 2018). 50 
 51 
Single-molecule experiments have shown that the cellular plasma membrane is partitioned into 52 
50-300 nm wide domains by the combined action of actin-based membrane cytoskeleton “fences” 53 
and anchored-transmembrane protein “pickets” (Kusumi and Sako, 1996). On the cell surface, 54 
organization and interaction of proteins and lipids have been proposed to occur on different time 55 
and length scales, from direct molecular interactions to transient association within nanoscopic 56 
domains. Lipid raft microdomains are critical for entry and budding of enveloped viruses and 57 
assumed to function as selective concentration devices for viruses and proteins and to serve as 58 
platforms for signal transduction for endocytosis (K. Simons, D. Toomre, 2000). Blocking one 59 
endocytic pathway is typically insufficient to reduce IAV infection, and the virus is capable of 60 
eliciting two or more endocytic pathways. The endocytic pathway may depend on the cell 61 
membrane context such as abundance of receptor tyrosine kinases (RTKs) and facileness to induce 62 
lipid raft clustering upon multivalent HA binding to receptor(s) (Grecco et al., 2011, Eierhoff et 63 
al., 2010). Clathrin-coated pits are 120-150 nm in diameter in human epithelial cells (Bretscher et 64 
al., 1980). Most IAV entry experiments have been conducted using lab adapted, pleomorphic, 65 
spherical virions with a diameter ranging from about 80-120 nm (Noda, 2011). Filamentous 66 
influenza virions, which are 100 nm x 20 µm in size, are thought to predominantly trigger 67 
macropinocytic uptake in cell culture (Rossman and Lamb, 2011).  68 
 69 
Following binding, a signalling circuit involving Rho kinase and phosphatidylinositol 4-70 
phosphate 5-kinase (PIP5K)-phopholipase C (PLC) which is regulated by intracellular Ca2+ 71 
regulates the clathrin-dependent and -independent uptake of IAV (Fujioka et al., 2013). A 72 
sialylated voltage-dependent Ca2+ channel (Cav1.2) acts as a functional receptor by binding to IAV 73 
PR8 HA (Fujioka et al., 2018). In Lec2 Chinese hamster ovary (CHO) cells that are deficient for 74 
sialic acids, infection is impaired but attachment and entry recovered when Ca2+-dependent (C-75 
type) lectins that bind carbohydrate structures on viral glycoproteins [i.e. dendritic cell-specific 76 
intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) and liver/lymph node-77 
specific intercellular adhesion molecule-3-grabbing integrin (L-SIGN)] were expressed (Londrigan 78 
et al., 2011). IAV does not efficiently infect Lec1 CHO cells deficient for N-acetylglucosaminyl 79 
transferase 1 (GnT1) indicating that the virus requires N-linked glycoprotein for entry (Chu and 80 
Whittaker, 2004). Using African green monkey kidney BSC-1 cells it was shown that 65% of 81 
influenza virus uptake is clathrin-dependent (Rust et al., 2004), and that the non-clathrin 82 
pathway is macropinocytosis-like and serum-inducible (de Vries et al., 2011). Epsin 1 is a cargo-83 
specific adaptor for IAV, and a clathrin-, ubiquitin-, and phospholipid-interacting protein. Its 84 
depletion specifically blocks clathrin-mediated IAV uptake, however, the resulting infectivity 85 
remains the same because IAV particles can divert to a non-clathrin pathway (Chen and Zhuang, 86 
2008). Thus, it is clear that IAV can alternate between clathrin and non-clathrin 87 
pathways.[MCK1][YY2]  88 
In GnT1-deficient CHO cells, virus macropinocytic uptake was blocked whereas dynamin-89 
dependent uptake was not (de Vries et al., 2012). Serum can induce dynamin-independent 90 
micropinocytosis-like uptake (de Vries et al., 2011). At the same time, - serum contains high 91 
levels of sialic acids and can act as decoy receptors that compete with virus binding to the cell 92 
surface.[MCK3] Such competitive binding can be neutralised by NA activity - a mechanism thought 93 
to be relevant for in vivo infections along the mucus-rich airway epithelium (Matrosovich et al., 94 
2004). Using African green monkey kidney BSC-1 cells it was shown that 65% of influenza virus 95 
uptake is clathrin-dependent (Rust et al., 2004), and that the non-clathrin pathway is 96 
macropinocytosis-like and serum-inducible (de Vries et al., 2011). Epsin 1 is a cargo-specific 97 
adaptor for IAV, and a clathrin-, ubiquitin-, and phospholipid-interacting protein. Its depletion 98 
specifically blocks clathrin-mediated IAV uptake, however, the resulting infectivity remains the 99 
same because IAV particles can divert to a non-clathrin pathway (Chen and Zhuang, 2008). Thus, 100 
it is clear that IAV can alternate between clathrin and non-clathrin pathways.[MCK4] 101 
 102 
Following endocytosis, IAV resides in a vesicle that undergoes three stages of motility 103 
accompanied by a maturation process that leads to late endosome (LE) and multivesicular body 104 
formation (Huotari and Helenius, 2011). Stage I is an actin-dependent movement in the cell 105 
periphery; stage II is a rapid directed motion towards the nucleus; stage III is a bi-directional, 106 
microtubule-dependent type of movement (Lakadamyali et al., 2003). Microtubules are important 107 
for influenza entry and infection is halved upon their depolymerisation by nocodazole (Yamauchi 108 
et al., 2011, Lozach et al., 2010).  109 
 110 




Multistep IAV uncoating in endosomes  115 
 116 
Viral uncoating is promoted by cellular cues, facilitators, and built-in mechanisms for uncoating 117 
(Yamauchi and Greber, 2016). Cellular cues come in many shapes and forms; from cell surface 118 
receptors to enzymes, scaffolds and chemicals that exist extracellularly or in endocytic vesicles, or 119 
in the cytosol. Enveloped Many enveloped and non-enveloped viruses including influenza, Ebola, 120 
Lassa, Rhino and Adeno link their uncoating program to the endocytic machinery (Staring et al., 121 
2018, Yamauchi and Helenius, 2013, Yamauchi and Greber, 2016). Furthermore, the endocytosis 122 
machinery provides an environment for IAV that allows separation of uncoating and assembly. 123 
The inner shell of the IAV virion is represented by a membrane-associated scaffold of matrix 124 
proteins, M1, that makes contacts with both vRNPs and the lipid envelope with the cytoplasmic 125 
tails of HA and NA in the lipid envelope  (Lamb and Choppin, 1983). In endosomes, IAV takes 126 
advantage of cues such as cathepsin cleavage, low pH and high K+  to promote viral fusion and 127 
uncoating (Stauffer et al., 2014, Edinger et al., 2015, Martin and Helenius, 1991). The NA of IAV 128 
H5N1 was shown to affect LAMP2 glycosylation at low pH, thereby potentially destabilizing the 129 
lysosomal glycocalyx and promoting endosomal escape (Ju et al., 2015).  130 
 131 
Uncoating can be split into two steps: priming within the endosomal compartment, then 132 
uncoating by host factors on the cytosolic surface or in thw close vicinity of LEs. During 133 
endocytic transit of incoming IAV particles, the M2 ion channel opens and the influx of protons 134 
and K+ ions affects M1 conformation, which subsequently dissociates interactions between HA C-135 
terminus and -M1, M1-M1 and M1-vRNPs, resulting in reduced viral particle rigidity (Stauffer et 136 
al., 2014, Li et al., 2014, Martin and Helenius, 1991). Once the endosomes reach an acidic 137 
environment of pH<6.0, M1 oligomers dissociate irreversibly into dimers resulting in a softening 138 
of the viral particle (Li et al., 2014, Zhang et al., 2012).This priming step is dependent on the a 139 
functional M2 channel and is completely stalled by the M2 blocker amantadine. Thus, priming in 140 
endosomes is an essential step in the IAV life cycle that instigates the full infectious capacity of 141 
the IAV particle (Fig. 1).  142 
 143 
Many enveloped viruses use an acid-activated fusion mechanism to create a fusion pore at the 144 
endosomal membrane and gain cytosolic access. Fusion is mediated by specialised transmembrane 145 
proteins on the viral envelope (Harrison, 2008). At a low pH (≅5.0-5.5) IAV HA undergoes 146 
conformational changes that brings viral and endosomal membranes in extreme proximity, 147 
triggering membrane fusion and generating micropits that transform into narrow connections 148 
that eventually form a fusion pore (Kanaseki et al., 1997, Lee, 2010, Chlanda et al., 2016). 149 
However, IAV fusion is not sufficient for M1 uncoating and for vRNPs to enter the nucleus 150 
(Martin and Helenius, 1991). Viral fusion can be effectively performed at the plasma membrane if 151 
the low pH trigger is supplied to virus bound on the cell surface (Stauffer et al., 2014, Helenius et 152 
al., 1980, White et al., 1981, Kielian, 2014). Experiments have shown that in the case of IAV, 153 
acid-triggered fusion alone is very inefficient in releasing the genome and that stepwise uncoating 154 
signals must be provided to make the viral core (M1 and vRNPs) uncoating-competent. Infectivity 155 
can be restored, by mimicking endocytic transit by pre-acidification of IAV particles in vitro 156 
(Stauffer et al., 2014). Furthermore, the high K+ concentration (≅120 mM) in LEs increases 157 
solubility of the vRNP bundle (Stauffer et al., 2014). The tetraspanin CD81, a top hit from 158 
multiple siRNA screens, was shown to be required for IAV fusion and endosomal escape (He et al., 159 
2013). Here, incoming IAV particles fused in CD81-positive endosomes, and CD81 depletion 160 
blocked viral entry (He et al., 2013).[MCK5][YY6] CD81 associates with tetraspanins and other 161 
tetraspanin-interacting proteins to form tetraspanin-enriched microdomains on cellular 162 
membranes (Hemler, 2005), and is also incorporated into budding virions (He et al., 2013). Such 163 
micodomains may contribute to viral fusion at LEs, however, the precise mechanism of how the 164 
presence of CD81 promotes viral fusion is unclear. 165 
 166 
IAV fusion and cytosolic uncoating 167 
 168 
RNAi and proteomic screening approaches have identified cellular proteins required for IAV 169 
fusion and uncoating (Yamauchi et al., 2011, Huotari et al., 2012, Gschweitl et al., 2016, Konig et 170 
al., 2010, Edinger et al., 2015, Pohl et al., 2014, Konig and Stertz, 2015, Edinger et al., 2014, 171 
Yanguez et al., 2018, Su et al., 2013, Banerjee et al., 2013, Miyake et al., 2019a, He et al., 2013). 172 
These are histone deacetylase 6 (HDAC6) (Banerjee et al., 2014), the nuclear import factor 173 
karyopherin-β2 (kKapβ2) (Miyake et al., 2019a), SPOPL/Cullin 3 (Gschweitl et al., 2016), ITCH 174 
(Su et al., 2013), EGFR substrate protein 8 (EPS8) (Larson et al., 2019), GRK2 (Yanguez et al., 175 
2018) and LY6E (Mar et al., 2018). The E3 ubiquitin ligase ITCH localises to LEs and ubiquitinates 176 
viral M1 to promote uncoating (Su et al., 2013). LY6E, a member of the LY6/uPAR family, is an 177 
interferon-stimulated gene (ISG) that enhances viral entry at the uncoating step (Mar et al., 2018). 178 
GRK2 is activated by IAV and was identified from phosphoproteomic-based kinase profiling of 179 
IAV infected cells. GRK2 is required for efficient IAV uncoating but its cellular target is unclear 180 
(Yanguez et al., 2018). EPS8 physically associated with incoming IAV viral cores and its depletion 181 
reduced uncoating (Larson et al., 2019). Eps15 is a ubiquitination target of CRL3SPOPL E3 ubiquitin 182 
ligase complex required for IAV uncoating and regulates intraluminal vesicle formation during 183 
endosome maturation (Gschweitl et al., 2016). Likewise cullin 3 depletion interferes with 184 
endosome maturation and as a consequence IAV uncoating is blocked (Huotari and Helenius, 185 
2011). Cytosolic IAV uncoating uses the aggresome processing pathway and HDAC6 for M1 shell 186 
breakage (Fig. 2), and kKapβ2 for removal of residual M1 from the surface of vRNPs, which leads 187 
to vRNP debundling and nuclear import (Banerjee et al., 2014, Kawaguchi et al., 2003, Hao et al., 188 
2013, Miyake et al., 2019a).  189 
  190 
After replication in the nucleus, progeny vRNPs are exported to the cytoplasm. This requires the 191 
assembly of a nuclear export complex consisting of the vRNP, M1 protein, and the viral nuclear 192 
export protein (NEP),[MCK7] which contains two nuclear export signals (NESs), in mediating the 193 
association of exportin1/XPO1/CRM1 with vRNPs in a so-called daisy chain arrangement (Akarsu 194 
et al., 2003, Huang et al., 2013, Neumann et al., 2000, O'Neill et al., 1998, Paterson and Fodor, 195 
2012). 196 
 197 
Could it be that incoming IAV cores retain the characteristics of membraneless liquid 198 
organelles?[MCK8][YY9] Recently, it was shown that during IAV replication viral inclusions display 199 
characteristics of liquid organelles (Fig. 1) (Alenquer et al., 2019). Using Fluorescence Recovery 200 
After Photobleaching (FRAP), viral inclusions formed by either PA-GFP or GFP-NP dynamically 201 
exchanged material with the exterior in a manner consistent with nucleoli and stress granules 202 
(SGs) [MCK10][YY11](Nikolic et al., 2016). These inclusions develop close to endoplasmic reticulum 203 
exit sites, segregate vRNPs from the cytosol and are thought to promote RNA-RNA interactions. 204 
Rab11, a marker for recycling endosomes, also plays a critical role in vRNP egress towards the 205 
plasma membrane (de Castro Martin et al., 2017, Eisfeld et al., 2011, Amorim et al., 2011). 206 
Biogenesis of IAV liquid inclusions enriched in vRNPs and Rab11 is dependent on continuous 207 
cycles of material between the ER and the Golgi, indicating that their distribution is spatially 208 
regulated (Alenquer et al., 2019). Could it be that incoming IAV cores retain the characteristics of 209 
membraneless liquid organelles?[MCK12] 210 
 211 
[insert Figure 2 here] 212 
 213 
Histone deacetylases (HDACs) in IAV entry: what sets HDAC6 apart from other HDACs 214 
 215 
Acetylation on lysine residues of histone and other proteins has been recognised as a major post-216 
translational modification that affects multiple aspects of protein function. Protein acetylation is 217 
regulated by the balance of enzymes with opposing activities: histone acetyltransferases (HATs) 218 
and histone deacetylases (HDACs) (Yang and Seto, 2008). HDACs are enzymes that catalyze the 219 
removal of acetyl groups from lysine residues located on histone and non-histone proteins. As 220 
shown in Figure 3, HDACs have 18 isofo[MCK13][YY14]rms that use either Zn2+- or nicotinamide 221 
adenine dinucleotide (NAD)+-dependent mechanisms to deacetylate lysine substrates; the former 222 
11 enzymes are of the histone deacetylase family, the latter 7 enzymes are of the silent 223 
information regulator 2 (Sir2) family (Seto and Yoshida, 2014). and HDACs can be categorised 224 
into four classes: class I HDACs are 400-500 amino acids long, and include HDAC1, HDAC2, 225 
HDAC3 and HDAC8. Class II HDACs are ∼1000 amino acids long; class IIa comprises HDAC4, 226 
HDAC5, HDAC7 and HDAC9, and class IIb comprises HDAC6 and HDAC10 (Valenzuela-227 
Fernandez et al., 2008). Class III comprises the Sir2-like deacetylases Silent Information Regulator 228 
(SIRT1)-SIRT7, ranging in size from 310-757 amino acids (Marks et al., 2003), while Class IV 229 
(HDAC11) HDACs areis a  Zn2+ dependent metalloproteases (Gregoretti et al., 2004, Haigis and 230 
Guarente, 2006) (Fig. 3[MCK15][YY16]). 231 
 232 
[insert Figure 3 here] 233 
 234 
Class I HDACs influence IAV infection in complex ways: a pan class I HDAC inhibitor increases 235 
IAV infectivity; HDAC1 and 2 are antiviral whereas HDAC3 and 8 are pro-viral (Yamauchi et al., 236 
2011). HDAC8 depletion induced centrosome splitting, an aberrant microtubule network and 237 
scattered LEs, impacting IAV entry and infection (Yamauchi et al., 2011). HDAC6, an a critical 238 
IAV uncoating factor, is mostly cytoplasmic with unique characteristics that distinguish it from 239 
the other HDACs: tandem catalytic domains with tubulin deacetylation activity and the presence 240 
of a zinc finger domain with that has homology to ubiquitin-specific proteases (ZnF-UBP), which 241 
and binds to unanchored ubiquitin (Fig. 4) (Zhang et al., 2006, Grozinger et al., 1999, Verdel et al., 242 
2000, Miyake et al., 2016). HDAC6 ZnF-UBP binds to ubiquitin at its C-terminal Gly-Gly residues 243 
unlike most other ubiquitin binding domains, which interact with the hydrophobic core of 244 
ubiquitin (Ouyang et al., 2012, Pai et al., 2007).  245 
 246 
[insert Figure 4 here] 247 
 248 
 249 
HDAC6 regulates cellular stress granules, aggresomes and phase separation 250 
 251 
HDAC6 is a versatile cytosolic deacetylase and some of its non-histone substrates are α-tubulin 252 
cortactin, Hsp90, cortactin, HIV-1 Tat and, DEAD box RNA helicase 3, and X-linked (DDX3X) 253 
[MCK17][YY18](Saito et al., 2019, Zhang et al., 2016, Huo et al., 2011, Hubbert et al., 2002, Kovacs et 254 
al., 2005, Zhang et al., 2007)(Reviewed in (Moreno-Gonzalo et al., 2018)). Most importantly, 255 
HDAC6 functions in the management of the cellular stress response and the management of 256 
misfolded proteins, phase separation, autophagy, pathogen sensing and neurodegeneration 257 
(Matthias et al., 2008, Miyake et al., 2016, Saito et al., 2019, Zhang et al., 2008, Boyault et al., 2007, 258 
Kawaguchi et al., 2003, Iwata et al., 2005, Hubbert et al., 2002, Kwon et al., 2007, Lee et al., 2010a, 259 
Lee et al., 2010b, Moreno-Gonzalo et al., 2018).  260 
 261 
HDAC6 participates in the formation of SGs and aggresomes (Kawaguchi et al., 2003, Kwon et al., 262 
2007). Misfolded proteins that result from genetic mutations, defective protein maturation, or 263 
environmental stress are polyubiquitinated and degraded by the proteasome system. Protein 264 
aggregates form when the proteasome is inadequate, and are harmful to cell survival and must be 265 
eliminated (Tran and Miller, 1999). In the cell, misfolded protein aggregates are transported and 266 
removed from the cytoplasm by dynein motors via microtubules to a membraneless organelle 267 
called the aggresome (Fig. 5)(Kawaguchi et al., 2003). Aggresomes were first identified in the 268 
characterisation of a mutant form of the aggregation-prone cystic fibrosis transmembrane 269 
conducting regulator CFTR-ΔF508 (Johnston et al., 1998). CFTR-ΔF508 is normally 270 
polyubiquitinated and degraded by the proteasome (Jensen et al., 1995, Ward et al., 1995). 271 
However, the proteasome cannot degrade aggregates but stimulates autophagy-dependent 272 
aggregate clearance by generating unanchored K63-linked ubiquitin chains via Poh1, a 273 
proteasomal deubiquitinase (Nanduri et al., 2015, Hao et al., 2013). Inhibition of Hsp90 also 274 
suppresses K63-linked ubiquitin chain formation and aggresome clearance (Nanduri et al., 2015). 275 
Here, HDAC6 plays a central role by regulating both the concentration and autophagic clearance 276 
of protein aggregates or aggresomes (Lee et al., 2010a, Iwata et al., 2005, Kawaguchi et al., 2003).  277 
 278 
Unanchored ubiquitin is a hallmark of misfolded proteins in the cell and is typically generated 279 
together with cell stress-induced misfolded proteins that are polyubiquitinated by the cellular 280 
ubiquitination machinery. These misfolded proteins are normally linked with ubiquitin K-48 (see 281 
details below) and degraded by the proteasome (Kawaguchi et al., 2003, Hao et al., 2013, Ouyang 282 
et al., 2012). When this fails due to negative conditions of the cellular environment, the protein 283 
waste complexes undergo further rounds of polyubiquitination and deubiquitination. This leads to 284 
generation of polyubiquitin chains that are ‘unanchored’ and not conjugated to any substrate 285 
protein. Poh1 – a deubiquitinase from JAMM/MPN+ family – is associated with the 26S 286 
proteasome (Yao and Cohen, 2002), and plays a role in the recycling of ubiquitin. During 287 
aggresome processing, unanchored ubiquitin that regulates HDAC6 function is generated by 288 
deubiquitinases such as Ataxin-3 (Ouyang et al., 2012), which associate with protein aggregates 289 
and the proteasome-residing Poh1 (Hao et al., 2013). 290 
 291 
The unanchored ubiquitin chains are recognised by the ZnF-UBP of HDAC6 (Ouyang et al., 2012). 292 
This binding activates recruitment of the molecular motor dynein to the dynein-binding region of 293 
HDAC6 in between the two catalytic domains, and myosin II. Hydrophobic protein-protein 294 
interactions retain the unanchored ubiquitin chains associated with the misfolded protein. Thus, 295 
the action of dynein motors transports the misfolded protein aggregate towards the microtubule-296 
organising centre (MTOC), leading to aggresome formation. The action of myosin II and Poh1 297 
promotes the disassembly of the aggresome. The catalytic activity of HDAC6 modulates 298 
aggresome clearance (Hao et al., 2013) and eventually the autophagic machinery or UPS degrades 299 
the misfolded protein (Moreno-Gonzalo et al., 2018). 300 
 301 
[Insert Figure 5 here, in color] 302 
 303 
HDAC6 uncoats IAV via ubiquitin chains and the aggresome pathway 304 
 305 
The aggresome pathway and IAV uncoating share many similarities. Following viral fusion, 306 
HDAC6 is recruited to the fusion site on LEs via viral unanchored ubiquitin, colocalising with 307 
M1-positive vesicles (Banerjee et al., 2014). M1 binds to the HDAC6 N-terminal domain to form 308 
an M1-HDAC6-polyubiquitin chain complex (Fig. 5). HDAC6 activation and triggering of the 309 
aggresome pathway in turn connects the M1-HDAC6-ubiquitin chain complex to molecular 310 
motors dynein (via the HDAC6 dynein-binding region) and myosin II (Fig. 4, 5). The mechanism 311 
of myosin II recruitment remains to be solved. When both microtubules and actin are 312 
depolymerised, IAV uncoating is completely inhibited (Banerjee et al., 2014).  313 
 314 
The co-existence of deacetylase-dependent and -independent functions of HDAC6 adds layers of 315 
complexity to the IAV infection phenotype observed upon full knockout of HDAC6. During viral 316 
entry the ZnF is important for uncoating, however, after vRNP import the deacetylase’s antiviral 317 
functions come into play. For example, HDAC6 restricts IAV replication by deacetylating the 318 
viral RNA polymerase PA subunit (Chen et al., 2019), and deacetylation of Lys909 of retinoic-acid 319 
inducible gene I (RIG-I) by HDAC6 promotes RIG-I oligomerisation and viral RNA sensing, 320 
activating mitochondrial antiviral signalling protein (MAVS)-IRF3-NF-kB and IFN-β (Choi et al., 321 
2016). Overexpression of HDAC6 leads to diminished viral budding due to induction of hypo-322 
acetylated tubulin (Husain and Cheung, 2014, Husain and Harrod, 2011). Therefore, the complex 323 
involvement of HDAC6 in the IAV life cycle must be interpreted with care (Zheng et al., 2017). 324 
 325 
How are ubiquitin chains made and packed into virions? 326 
 327 
Ubiquitination is a prevalent post-translational modification addition of ubiquitin (a small 8.5 kDa 328 
protein composed of 76 amino acids) to other proteins, that thus alters altering the protein 329 
function, localisation, trafficking and its degradation by the proteasome. Ubiquitin itself can be 330 
ubiquitinated on 8 different sites, namely seven lysines and the N-terminal methionine. The most 331 
prevalent types of ubiquitin linkages are K-48 and K-63 linkages. The former is known to lead to 332 
proteasomal degradation of the substrate protein, and the latter is involved in endocytosis, 333 
trafficking and enzyme activity (Komander and Rape, 2012, Kulathu and Komander, 2012).  334 
 335 
Mechanistically, the process of protein ubiquitination involves a three-step enzymatic cascade, 336 
which starts with the ubiquitin-activating enzyme E1, followed by the ubiquitin-conjugating 337 
enzyme E2, and the ubiquitin ligase E3. Ubiquitin is activated in an ATP-dependent manner, 338 
when a high-energy thioester bond is formed between the C-terminus of ubiquitin and an 339 
internal cysteine residue of the ubiquitin-activating enzyme E1. Activated ubiquitin is then 340 
transferred onto the active site cysteine of one of the E2-conjugating enzymes. Finally, the 341 
formation of an isopeptide bond is catalyzed by E3 ubiquitin ligases, which link ubiquitin 342 
moieties to target proteins or elongate a polyubiquitin chain (Ciechanover, 2015, Rudnicka and 343 
Yamauchi, 2016). Unanchored ubiquitin chains[MCK19][YY20] ranging from mono- to hepta-344 
ubiquitin are packaged into IAV virions in producer cells and can be detected in roughly 60 % of 345 
individual particles by super-resolution fluorescence microscopy (Fig. 6) (Banerjee et al., 2014). It 346 
is remarkable that IAV virions package such unanchored ubiquitin chains, and they are mostly 347 
packed between the viral envelope and M1 layer to ensure cytosolic exposure following viral 348 
fusion at LEs (Fig. 5) (Banerjee et al., 2014). Open questions remain: Which ubiquitin modifying 349 
enzymes generate the ubiquitin chains? How are the chains packaged into the virion? Is 350 
packaging passive or active? What about other enveloped viruses?[MCK21] 351 
 352 
[insert Figure 6 here] 353 
 354 
Genome-wide siRNA screening, OMICs and other approaches have identified E3 ubiquitin ligases 355 
that are important for the replication cycle of IAV. These are Cullin 3, ITCH, TRIM 25, NEDD4, 356 
and UBR4 (Huotari et al., 2012, Gschweitl et al., 2016, Su et al., 2013, Tripathi et al., 2015, 357 
Meyerson et al., 2017, Chesarino et al., 2015). Cullin 3, a member of the RING ubiquitin protein 358 
ligase family, is critical for proper functionality of the endosome maturation program and thus its 359 
effect on IAV uncoating is indirect. ITCH, a HECT-type family of E3 ubiquitin ligases, is 360 
important for IAV uncoating and was shown to ubiquitinate M1 in in vitro ubiquitination assays 361 
(Su et al., 2013). Its localisation to LEs suggests that ITCH can be present or recruited to viral sites 362 
of fusion on the LE surface in order to ubiquitinate M1. An influenza OMICs study of the hit 363 
genes from eight independent RNAi screen datasets identified UBR4, an UBR-box containing N-364 
recognin family of E3 ubiquitin ligases required for efficient autophagy and membrane 365 
morphogenesis (Tasaki et al., 2013, Parsons et al., 2015). UBR4 interacts with viral M2 and 366 
promotes its translocation to the plasma membrane during late stages of viral replication (Tripathi 367 
et al., 2015). Interestingly, in UBR4 depleted cells, M2 is unable to reach the plasma membrane 368 
and is degraded by autophagy, the consequences being thus resulting in inhibited inhibition of 369 
viral budding from the plasma membrane (Tripathi et al., 2015). 370 
 371 
Whether packaging of ubiquitin chains is promoted by any of these identified E3 ubiquitin ligases, 372 
or any of the viral proteins, is unknown. However, it is likely that ubiquitin modifiers involved in 373 
aggresome processing are important. Initial exposure of ubiquitin chains during early viral 374 
infection recruits HDAC6 via the ZnF-UBP to the surface of LEs. A single amino acid substitution 375 
(W1182A in human HDAC6, W1116A in mouse) blocks unanchored ubiquitin binding to the 376 
ZnF and inhibits aggresomes and viral uncoating (Hao et al., 2013, Banerjee et al., 2014). That the 377 
ubiquitin binding capacity of HDAC6 is necessary and sufficient to promote IAV uncoating 378 
indicates the importance of the packaged ubiquitin chains. The linkages and various heterotypes 379 
heterotypicity [MCK22][YY23]of the ubiquitin chains await elucidation. It is also clear that a fraction 380 
of IAV uncoating occurs without the aid of HDAC6 (Banerjee et al., 2014).  381 
 382 
Karyopherin-β2 (transportin-1/TNPO1): a cellular condensate surveillance factor 383 
 384 
M1 uncoating and vRNP debundling is are promoted by karyopherin-β2 (kKapβ2) - also called 385 
transportin-1 (TNPO1) - an import factor of RNA-binding proteins such as heterogenous nuclear 386 
ribonucleoprotein A1 (hnRNP A1), FUS and HuR (Twyffels et al., 2014). Kapβ2 was identified as 387 
the import factor for hnRNP A1 in mammalian cells (Pollard et al., 1996, Fridell et al., 1997, 388 
Nakielny et al., 1996). A very similar protein named karyopherin-β2B or transportin-2 was 389 
discovered (Siomi et al., 1997, Shamsher et al., 2002) and later shown to have two isoforms A and 390 
B that share 84% and 92% sequence similarity with karyopherin-β2 (Rebane et al., 2004). 391 
Structural analysis of complexes between kKapβ2 and its nuclear localisation signals (NLSs) 392 
showed common patterns among various kKapβ2-dependent NLSs and was these were 393 
collectively termed PY-NLS (Fig. 7, 8). Canonical PY-NLSs respond to physical rules: they should 394 
be included in a basic and structurally disordered region. Cargoes that bear the PY-NLS are 395 
mostly RNA-binding proteins with many of them having RNA processing or transcription activity 396 
(Lee et al., 2006). The PY-NLS of hnRNP A1 is also known as the “M9” sequence.  397 
 398 
[insert Figure 7 here] 399 
 400 
The PY-NLS is defined by loose sequence motifs (N-terminal hydrophobic or basic motifs and a 401 
C-terminal (R/K/H)X2–5PY motif), structural disorder, and an overall basic charge (Lee et al., 402 
2006). Recently it was shown that kKapβ2 binds with high affinity to the N-terminal tail of 403 
histone H3 even though it lacks a recognisable PY-NLS. The N-terminal tail of H3 contacts many 404 
of the same kKapβ2 residues as that of a typical PY-NLS (Soniat and Chook, 2016). 405 
Combinatorial mixing of energetically weak and strong motifs, PY-NLS Epitopes 1, 2, and 3, 406 
results in a range of kKapβ2 affinities suitable for nuclear import and generates large sequence 407 
diversity of PY-NLSs (Fig. 8) (Suel et al., 2008). For example, H3 uses a very strong EEpitope 408 
1[MCK24][YY25] (12GGKAPRK18) to compensate for the lack of the often-conserved PY epitope 409 
(Soniat and Chook, 2016). There are many other cargos without a PY sequence-NLS that binds 410 
kKapβ2 such as N-terminal tail of histone H4 and ribosomal protein rpL23A , the RNA-editing 411 
enzyme ADAR1 (Barraud et al., 2014), IAV M1 (Miyake et al., 2019a), , viral proteins IAV M1 412 
(Miyake et al., 2019a), HIV-1 REV (Fig. 8) (Arnold et al., 2006), HIV-1 CA (Fig. 8) (Fernandez et 413 
al., 2019), and HPV E6 (Le Roux and Moroianu, 2003). The IAV M1 PY-NLS contains Epitopes 1 414 
(18GPL20) and 2 [MCK26][YY27](24IAQR27), of which Epitope 1 overlaps with the binding motif of HB-415 
64, an M1 monoclonal antibody that detects M1 uncoating (Fig. 8) (Miyake et al., 2019a). The 416 
HIV-1 CA PY-NLS Epitope 1 (88AGPI91)  overlaps with the unstructured non-canonical 417 
cyclophilin A (CypA) [MCK28]binding site (88AGP90) (Fig. 8) (Liu et al., 2016). 418 
 419 
[insert Figure 8 here (fit to half of page-width)] 420 
 421 
The link between IAV uncoating and management of cellular condensates 422 
 423 
Viruses hijack ubiquitous processes to execute the viral uncoating program. Protein 424 
disaggregation is central to the maintenance of a healthy state inside the cell and to ensure 425 
longterm cell survival. To understand viral uncoating it is critical to dissect the cell biological 426 
mechanisms of protein disaggregation and degradation (Yamauchi and Greber, 2016). To uncoat, 427 
IAV uses aggresome processing (Banerjee et al., 2014), vaccinia virus uses the ubiquitin 428 
proteasome system (UPS) (Schmidt et al., 2013b, Schmidt et al., 2013a), polyomaviruses use 429 
endoplasmic reticulum-associated degradation (ERAD) (Geiger et al., 2011, Inoue and Tsai, 2011, 430 
Schelhaas et al., 2007), and IAV and HIV-1 use nuclear import receptor (NIR)-mediated 431 
disaggregation (Guo et al., 2018, Yoshizawa et al., 2018, Miyake et al., 2019a, Fernandez et al., 432 
2019). 433 
 434 
Liquid-liquid phase separation (LLPS) is a common mechanism contributing to formation of 435 
membrane-less organelles (Banani et al., 2017, Hyman et al., 2014). SG[MCK29]s and aggresomes are 436 
membrane-less organelles that form when cells are under specific environmental stresses. SGs 437 
represent a pool of mRNAs stalled in translation and are composed of ribonucleoproteins (RNPs) 438 
(Protter and Parker, 2016). HDAC6 colocalises with the SG-marker Ras-GTPase-activating 439 
protein SH3 domain-binding protein 1 (G3BP-1) under various stress conditions (Tourriere et al., 440 
2003). It was recently found that HDAC6 preferentially targets acetylated lysines in intrinsically 441 
disordered regions (IDRs) of the SG component DDX3X (Saito et al., 2019). Stresses such as 442 
oxidative and osmotic stress, and  or inhibition of translation induced the acetylation of lysines in 443 
IDRs by the acetyltransferase CBP. Acetylation of DDX3X-IDR1 inhibited LLPS, and its 444 
deacetylation by HDAC6 was necessary for the assembly of large, mature SGs (Saito et al., 2019). 445 
 446 
Aggresomes are misfolded protein aggregates that are enriched at microtubule organising centres 447 
by microtubule-dependent motors and subsequently processed by autophagy (Tyedmers et al., 448 
2010). Recent studies have shown that LLPS driven by multivalent macromolecular interaction is 449 
an important organising principle for biomolecular condensates. Classic organelles, like the 450 
endoplasmic reticulum or Golgi apparatus are compartments defined by surrounding lipid bilayer 451 
membranes. Many cellular compartments such as Cajal bodies and PML bodies, SGs and 452 
aggresomes are not separated by membranes (Banani et al., 2017). The physical processes that 453 
promote the formation of membraneless compartments such as P granules (perinuclear 454 
membraneless compartments composed of proteins and RNAs found in germ cells of 455 
Caenorhabditis elegans) are liquid-like. As such, P granules fuse with one another and relax back 456 
into a spherical shape (Brangwynne et al., 2009). RNA granules are condensates that require 457 
dynamic regulation by chaperones, ATP-dependent disaggregates and molecular motors 458 
(Kroschwald et al., 2015, Jain et al., 2016). 459 
 460 
What is most striking about the cellular function of kKapβ2 is its significant role in the 461 
regulation of LLPS that is also connected to HDAC6 deacetylase activity and maturation of SGs 462 
(Fig. 9). Kapβ2 suppresses phase separation and SG association of FUS [MCK30]by chaperoning it 463 
and promoting solubility – a function that is absent in the neurodegenerative disease amyotrophic 464 
lateral sclerosis (ALS) in which disease-lined mutations in the FUS NLS impair Kapβ2 binding 465 
(Hofweber et al., 2018). It is thought that NLSs constitute disaggregation signals in the cytoplasm 466 
and that nuclear import receptors such as kKapβ2 disaggregate NLS-bearing cargo and can 467 
reverse phase separation of RNA-binding proteins (Guo et al., 2018, Yoshizawa et al., 2018). Kap468 
β2 promotes RNA-binding protein solubility and suppresses their phase separation and SG 469 
association. An example is the fused in sarcoma (FUS) gene which is a component of the hnRNP 470 
complex that contains a PY-NLS recognised by kKapβ2 (Hofweber et al., 2018) (Fig. 8).[YY31] 471 
 472 
[Insert Figure 9 here, in color] 473 
 474 
How does kKapβ2 uncoat incoming influenza viruses? As an importin, kKapβ2 recognises a PY-475 
NLS on its cargo. The IAV M1 N-terminus contains epitopes 1 and 2 [MCK32]of a PY-NLS of which 476 
Gly18 is critical for recognition by Kapβ2 (Fig. 8) (Miyake et al., 2019a). Ser17 and Pro19 of the 477 
PY-NLS are buried interface residues of the N domains of the neutral pH M1 dimer (Harris et al., 478 
2001). The M1 N-terminal residues 18-GPL-20 are also important for recognition by HB-64, a 479 
monoclonal anti-M1 antibody that reacts preferentially to uncoated M1 during virus entry 480 
(Miyake et al., 2019a, Banerjee et al., 2013). Priming in LEs (pH<6.0) induces conformational 481 
changes within the viral core resulting in the exposure of M1 G18, facilitating kKapβ2 binding 482 
and promoting disaggregation of M1-M1 and vRNP-M1 complexes, leading to vRNP debundling 483 
(Miyake et al., 2019a). Overexpression of M9-NLS (from hnRNP A1) competed with M1 484 
uncoating (Miyake et al., 2019a). In the absence of endosomal priming, the incoming vRNPs-M1 485 
do not dissociate and vRNPs fail to enter the nucleus (Martin and Helenius, 1991, Stauffer et al., 486 
2014). This indicates that the acidification cue during priming is critical for M1 PY-NLS exposure 487 
and kKapβ2-mediated uncoating. Newly synthesised M1 monomers, however, did do not 488 
interact with kKapβ2, reflecting that kKapβ2-M1 interaction is dependent on acidification of 489 
high-order M1 oligomers that is are present in virions (Miyake et al., 2019a). This mechanism 490 
prevents vRNP debundling or M1 uncoating by kKapβ2 from happening during assembly.  491 
 492 
Challenges in live imaging IAV endosomal escape (Box) 493 
 494 
During virus entry conformational changes within the influenza viral capsid or HA are induced 495 
by cellular cues (reviewed in (Yamauchi and Greber, 2016)). Conformational changes can be 496 
detected by specific monoclonal antibodies (such as one recognising the HA acid-form) used for 497 
immunofluorescence quantification by automated microscopy and fluorescence activated cell 498 
sorting (FACS) (Banerjee et al., 2013, Yanguez et al., 2018, Miyake et al., 2019a, Larson et al., 2019, 499 
Gschweitl et al., 2016, Mar et al., 2018). HA acidification triggers lipid mixing between 500 
membranes of the virus and LEs, and formation of a fusion pore (White et al., 1981, Helenius, 501 
2013, Harrison, 2008). The hemifusion/fusion of a viral envelope with the endosomal membrane 502 
can be detected by viral labelling with lipophilic dyes administered at a self-quenching 503 
concentration. The dye dequenches upon low pH-induced lipid mixing, resulting in increased 504 
fluorescence that can be readily detected by fluorescence microscopy or fluorescence activated 505 
cell sorting (FACS). This method has been used successfully for a variety of virus entry studies 506 
(Banerjee et al., 2013, Sakai et al., 2006, Krzyzaniak et al., 2013, Pohl et al., 2014, Rowse et al., 507 
2015, Zaitseva et al., 2010, Lakadamyali et al., 2003).  508 
 509 
Virus fusion assays using liposomes, lipid droplets, or lipid bilayers have been combined with 510 
spectrofluorimetry or total internal reflection fluorescence (TIRF) microscopy equipped with a 511 
microfluidic device. These methods allow measurement of fusion kinetics and viral content 512 
release (Floyd et al., 2008, Wessels et al., 2007). In addition, cryo electron tomography can be 513 
used to quantify sequential membrane remodelling during influenza virus-liposome fusion (Gui et 514 
al., 2016, Lee, 2010, Chlanda et al., 2016). Specifically, these steps include HA mediated dimpling 515 
of the liposomal membrane, pinching, formation of a tightly docked interface of viral and 516 
liposomal membranes followed by M1 dissociation, hemifusion and full fusion (Gui et al., 2016). 517 
It is thought that small pores on the viral/endosomal membranes may initially form to proceed 518 
into a pore large enough for viral penetration (Zimmerberg et al., 1994). It is also thought that 519 
receptor-bound HAs are not able to carry out fusion (Dobay et al., 2011). Increased lability of the 520 
particle by endosomal priming could increase the number of non-receptor-bound HA trimers that 521 
come into proximity of the limiting membrane of the LE.  522 
 523 
Discrimination between hemifusion/fusion in cells requires a virus content release assay in which 524 
a dye or fluorophore within the particle is released into the cytosol. An example is HIV-1 grown 525 
in cyclophilin A (CypA)-DsRed expressing cells that incorporate CypA into the viral capsid, thus 526 
allowing the progeny particles to be used for virus content release imaging studies (Francis et al., 527 
2016). GFP-Vpr has also been used to detect content release during HIV-1 entry into host cells 528 
(Desai et al., 2014). For IAV there are no robust content release assays compatible with live cell 529 
imaging, apart from a recently reported quantum dot (QD) labelling approach of the viral RNA 530 
polymerase subunit (Qin et al., 2019). To circumvent this influenza virus-like particles (VLPs) 531 
with a β lactamase fused to the N-terminus of M1 (BlaM1) have been used to detect full fusion 532 
and pore formation in cells (Tscherne et al., 2010). In this approach, CCF2/4 (a green dye) is 533 
cleaved by β lactamase released into the cytosol which alters the dye to a blue fluorescence. 534 
These VLPs, however, are not suited to study post-fusion uncoating and nuclear import events. 535 
 536 
The interferon induced transmembrane protein 3 (IFITM3) inhibits the cytosolic entry of many 537 
enveloped and some non-enveloped viruses (Smith et al., 2014). The antiviral properties of 538 
IFITM1, 2 and 3 were only discovered in 2009 in an RNAi screen for regulators of influenza 539 
infection (Brass et al., 2009). IFITM3-mediated inhibition of IAV entry and replication is of 540 
particular importance. Two single nucleotide polymorphism (SNPs); one in the coding region 541 
(rs12252-C) and another in the promoter region (rs34481144) was shown to regulate severity of 542 
influenza in human patients (Allen et al., 2017, Everitt et al., 2012). The rs34481144 allele 543 
regulates IFITM3 expression by determining methylation-dependent binding of the CTCF 544 
transcriptional repressor (Allen et al., 2017). The mechanism by which IFITM3 restricts virus 545 
entry remains controversial. Li and colleagues showed that IFITM3 blocks viral hemifusion by 546 
increasing membrane rigidity in IFITM3-overexpressing cells (Li et al., 2013). Desai and 547 
colleagues showed using single virus particle analysis of Alexa Fluor 488- and DiD-labeled IAV 548 
and influenza pseudovirus that IFITM3 inhibited fusion pore formation at late endosomes but 549 
lipid mixing happened normally (Desai et al., 2014).  550 
(end of Box) 551 
 552 
vRNP nuclear import 553 
 554 
The end-point of influenza virus entry is the nuclear import of the uncoated vRNPs, which is an 555 
importin α/β-dependent process regulated by a classical NLSs (Boulo et al., 2007). Therefore, 556 
IAV hijacks two distinct nuclear import machineries during viral entry. The viral RNP is made of 557 
oligomeric NP, the RNA genome and viral polymerase (Moeller et al., 2012). One NP molecule 558 
binds 24-27 nucleotides in vivo (Area et al., 2004, Martin-Benito et al., 2001) and also has two sets 559 
of NLS, ensuring robust nuclear import of uncoated vRNPs (Eisfeld et al., 2015, Wu et al., 2007). 560 
When influenza vRNPs free of M1 were microinjected into cells, their nuclear accumulation was 561 
observed after 1 h of injection. Nuclear uptake occurred whether the vRNPs were prepared at 562 
neutral pH or extracted from viruses at acidic pH (pH 5.5) (Kemler et al., 1994). Cores that 563 
consisted of vRNPs and M1 could not be uptaken imported into the nucleus. Thus the removal of 564 
M1 by kKapβ2 causes the dissociation of vRNPs from each other, ensuring that they are small 565 
enough to pass through the nuclear pore (Bui et al., 1996, Kemler et al., 1994, Miyake et al., 566 
2019a). During cell entry the accumulation of vRNPs in the nucleus can be detected by 567 
immunofluorescence or fluorescence in situ hybridisation (FISH) (Chou et al., 2013, Banerjee et 568 
al., 2013, Pohl et al., 2014) or by microinjection of purified vRNPs (Kemler et al., 1994, Babcock 569 
et al., 2004). Using single-particle tracking of microinjected, fluorescently labelled vRNPs, it was 570 
shown that vRNPs undergo multiple rounds of binding and release before finally being 571 
translocated through the NPC (Babcock et al., 2004). A recent study used quantum dot (QD)-572 
bound IAV polymerase subunit PA to image incoming IAV PR8 strain vRNPs. In MDCK cells, 573 
incoming vRNPs exited from Rab7-positive LEs 30 to 90 minutes after infection (Qin et al., 2019). 574 
Here, separation of different vRNP segments were observed simultaneously or soon after the viral 575 
particles separated from Rab7-positive LEs, suggesting that M1 uncoating and vRNP debundling 576 
are events that take place rapidly at the LE surface. Following LE exit the QD-vRNPs translocated 577 
into the nucleus in a three-stage movement and exhibited two types of diffusion patterns in the 578 
nucleus (Qin et al., 2019). 579 
 580 
How IAV prevents uncoating during assembly 581 
 582 
In a series of elegant experiments Bui et al. showed that recombinant M1 expressed via a Semliki 583 
Forest Virus vector in cultured cells associates with vRNPs and inhibits their nuclear import. This 584 
interfering activity was eliminated after transient acidification of the cytosol to pH values 585 
approaching that of the late endosome (pH 5.0 to 5.5) using a NH4Cl-prepulse protocol, after 586 
which the incoming vRNPs were able to enter the nucleus (Bui et al., 1996).  587 
 588 
After replication in the nucleus, progeny vRNPs are exported to the cytoplasm via M1 and NEP. 589 
Here, the exported vRNPs are prevented from re-import into the nucleus due to binding to M1 590 
protein (Whittaker et al., 1996, Babcock et al., 2004).  591 
 592 
How can a virus be assembled in an infected cell and disassemble during entry into an uninfected 593 
cell? The first possibility is that the virus capsid is assembled as a stable structure in an infected 594 
cell and rendered metastable, for example by limited proteolysis, such that it can receive cues 595 
from the host (Greber et al., 1994). The second possibility is that the virus particle remains the 596 
same during assembly and egress but the infected and uninfected cells are different i.e. an 597 
uncoating factor may be activated during viral entry but rendered inactive during viral assembly. 598 
A third possibility is that the virus is unchanged but assembly and uncoating are spatially 599 
separated - viruses that undergo endocytosis use this strategy among others. [MCK33] 600 
 601 
Low pH in LEs can prime influenza virus cores for disassembly by specifically causing M1 602 
dissociation and allowing the vRNPs to enter the nucleus (Martin and Helenius, 1991). 603 
Remarkably, newly assembled progeny M1-vRNP complexes in the cytosol of infected cells are 604 
also dissociated by acidification. Using a heterokaryon system, Bui et al. showed that the removal 605 
of M1 from progeny vRNPs (that have exited the nucleus of an infected cell) by brief acidification 606 
allows vRNPs to re-enter the nucleus of a non-infected cells (Bui et al., 1996)[MCK34][YY35]. Thus, 607 
acidic pH inside endosomes serves as a critical switch that allows M1 to carry out its multiple 608 
functions in the uncoating, nuclear transport, and assembly of vRNPs. Finally, Figure 10 609 
summarises the stepwise entry of IAV into host cells from attachment, uptake (clathrin-mediated 610 
endocytosis or macropoinocytosis), priming in endosomes by endosome maturation, viral fusion 611 
with LEs and fusion pore formation, M1 shell uncoating by HDAC6, vRNP debundling by kKapβ612 
β2, and vRNP import into the nucleus (Fig. 10). 613 
 614 
[insert Figure 10 here, in color, rotate 90 degrees counter clock-wise to fill one page] 615 
 616 
Kapβ2 is a The emerging concept of uuniversal uncoating factors[MCK36] 617 
 618 
As shown in Figure 11, Karyopherin-β2 is emerging as a universal uncoating factor for 619 
enveloped RNA virusesIt is logical that multiple viruses hijack Kapβ2, a key player in the 620 
regulation of LLPS, for uncoating by containing a PY-NLS in their capsid protein. and has been 621 
shown to use a similar mechanism to uncoat IAV and HIV-1 (Fig. 11) (Miyake et al., 2019a, 622 
Fernandez et al., 2019). there is a remarkable similarity between the uncoating mechanisms of 623 
IAV and HIV-1 uncoating suggests that usage of PY-NLS is a common RNA virus uncoating 624 
strategy. Similar Potential PY-NLS ssequences with a loose consensus of  ɸ-G/A/S-ɸ-ɸ (where ɸ is 625 
a hydrophobic side chain) (Lee et al., 2006) are found in the coat proteins of flaviviruses and 626 
filoviruses., however,Whether if thesesuch sequences contribute to viral uncoating remains to be 627 
seen. Kapβ2 binds unstructured NLSs (Lee et al., 2006). For Both viruses possess a PY-NLS in their 628 
shell protein (Fig. 8) which is recognised by Kapβ2 in the cytosol. IAV M1, Gly18 and its 629 
adjacent hydrophobic residues is are important for  is critical for viral infectivity, and primed 630 
G18A mutant IAV virions failed to interact with kKapβ2 interaction. G18A mutant virions 631 
exhibit a dual negative effect on viral assembly and uncoating, which greatly compromises 632 
infectivity (Miyake et al., 2019a). Interestingly, X-ray crystallography and structural analysis of 633 
M1 G18A showed the disappearance of a cavity present in the WT M1 (L1/L3 loop region). 634 
indicating that Tthis structural alteration likely impacts M1 binding to kKapβ2 , as well as, HB-635 
64 monoclonal antibody M1 binding (Miyake et al., 2019a). Kapβ2 is known to bind 636 
unstructured NLSs (Lee et al., 2006) . It is unclear which part of M1 dimer becomes disordered for 637 
optimal Kapβ2 bindingT. For example, the disordered linker region between the N- and C-638 
terminal domains of M1 is a candidate, due to itsbecomes  increasing susceptible to limited 639 
protoelysis disordered nature and after low pH/high K+ treatment priming-induced exposure 640 
(Stauffer et al., 2014). Though the linker is not part of the canonical PY-NLS (Fig. 8) it may 641 
contribute to kapβ2 binding due to its physical proximity to G18the PY-NLS in the three-642 
dimensional M1 structure. Thus, the PY-NLS of M1 is most likely to be unconventional and may 643 
recruit kapβ2 only under a specific structural context that is active during viral entry. That 644 
nNewly synthesised M1 failsed to interact with kapβ2 suggests that the PY-NLS of M1 recruits 645 
kapβ2 only under a structural context that is present during viral entry (Miyake et al., 2019a). 646 
This would separate viral uncoating and assembly and be beneficial for IAV.  647 
 648 
For HIV-1, Glycine 89 of HIV-1 CA overlaps with the unstructured non-canonical cCypA 649 
[MCK37]binding site (88A88-G89-P90) (Fig. 8) (Liu et al., 2016). Since a single cCypA bridges two CA 650 
molecules from adjacent hexamers, a sub- stoichiometric level of cCypA stabilizes the capsid and 651 
protects premature uncoating, thus promoting reverse transcription in all cell types (Sayah and 652 
Luban, 2004). Glycine 89 is also crucial for kKapβ2 binding to the CA lattice, and for uncoating 653 
and subsequent nuclear import of the HIV-1 genome. The G89V mutant HIV-1 disposed of the 654 
kKapβ2-dependent phenotype for cell entry albeit with deleterious effects on viral infectivity. 655 
Recombinant kKapβ2 protein induced structural damage todisassembles purified wt HIV-1 656 
capsid/nucleocapsids (CANC[MCK38]) whereas  G89V mutant [YY39]capsid/nucleocapsids CANC 657 
waswere unaffected. Molecular docking simulations suggested that kKapβ2 may insert itself 658 
between capsid hexamers, which could induce strong steric hindrance and uncoating (Fernandez 659 
et al., 2019). To summarise, kapβ2 is emerging as a universal viral uncoating factor. Thus,It is 660 
logical that, for efficient viral uncoating and disaggregation of viral capsids, RNA viruses have 661 
evolved to hijack kapβ2, a key player in the regulation of LLPS, for efficient viral uncoating and 662 
disaggregation of incoming capsids. It is logical that multiple viruses hijack Kapβ2, a key player 663 
in the regulation of LLPS, for uncoating by containing a PY-NLS in their capsid protein. 664 
 665 
[insert Figure 11 here] 666 
 667 
Concluding remarks 668 
 669 
Influenza viruses are pathogens of enormous medical and economic impact. According to the 670 
World Health Organization (WHO), annual influenza epidemics result in an estimated 3–5 671 
million cases of severe illness and 290,000 to 650,000 deaths worldwide each year. The virus’ 672 
zoonotic nature, its segmented genome, and the error-prone viral RNA polymerase means that 673 
IAV can undergo antigenic alterations and genetic reassortment that can lead to an unexpected 674 
pandemic. Current seasonal influenza virus vaccines do not provide sufficient protection to 675 
alleviate the annual impact of influenza and cannot confer protection against potentially 676 
pandemic influenza. The lack of protection is due to rapid changes of the viral epitopes targeted 677 
by the vaccine and the often suboptimal immunogenicity of current immunization strategies 678 
(Nachbagauer and Palese, 2019). Current and past IAV antivirals target the viral proteins NA 679 
(oseltamivir, Tamiflu®), the RNA polymerase (baloxavir marboxil, Xofluza) or M2 channel 680 
(amantadine). That amantadine was historically effective (until viral resistance spread) indicates 681 
the importance of priming and uncoating in a physiological context and for IAV pathogenicity. 682 
During the last decade, genome-wide screens using siRNA, haploid cells, and CRISPR/Cas 683 
identified a multitude of host cell factors that promote viral entry and infection. However, not 684 
much is known about the precise mechanism of action. For such findings to develop into viable 685 
cell-targeted antiviral therapies, they require mechanistic dissection of the interplay that occurs at 686 
the interface of virus and host. In the future, we may be able to develop antiviral strategies that 687 
complement influenza vaccines, and also identify universal uncoating pathways used by 688 
enveloped RNA viruses. The 2020s holds promise in the conceptual advancement of broadband 689 
antiviral therapeutics that target cellular machineries essential for the entry and uncoating of 690 
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Figure legends 1260 
 1261 
Figure 1  1262 
The influenza A virus life cycle. After virion binding to cell surface sialic-acid containing 1263 
receptors the particle is endocytosed into vesicles. As the endosome matures, virions undergo 1264 
priming by acidic pH followed by viral fusion with the late endosomal membrane, M1 uncoating, 1265 
and vRNP debundling. The vRNPs are nuclear imported by importin α/β after which viral 1266 
replication takes place inside the nucleus. After replication, progeny vRNPs are trafficked to the 1267 
plasma membrane in a Rab11- and endoplasmic reticulum-dependent manner as the vRNPs 1268 
separate into membraneless organelles and eight vRNPs are bundled. Budding takes place from 1269 
lipid rafts into the extracellular space. Note that M1 and vRNP uncoating can take place on the 1270 
cytosolic surface of LEs or in their vicinity. (Goodsell et al., 2019). Three-dimensional structure 1271 
data: M1 (PDB ID: 1EA3); HA (PDB ID: 2IBX); NA (PDB ID: 6CRD); M2 (PDB ID: 3BKD); 1272 
Ubiquitin (PDB ID: 1UBQ). 1273 
 1274 
Figure 2 1275 
Mechanistic model of HDAC6-mediated IAV M1 uncoating. After endocytosis, the IAV particle is 1276 
trafficked towards the nucleus. As endosomes mature, their internal pH reduces becomes acidic, 1277 
and triggersing HA-mediated viral fusion with the limiting membrane of the late endosome. This 1278 
leads to fusion pore formation, and the viral core consisting of M1 and vRNPs gains access to the 1279 
cytoplasm. The virally packaged unanchored ubiquitin is exposed to the cytosolic surface of the 1280 
endosomes, acting as bait to recruit the HDAC6 protein by its ZnF-UBP which activates 1281 
aggresome processing, and the dynein and myosin II binding capacity of HDAC6. The IAV M1 1282 
also binds to the N-terminus of HDAC6, resulting in the linking of M1 to microtubule motors and 1283 
the actomyosin network. The shearing force generated by the molecular motors eventually leads 1284 
to the dismantling of the viral core and release/exposure of the vRNPs to the cytoplasm after 1285 
which they are further debundled by Karyopherin-β2 (not shown) (Banerjee et al., 2014, Miyake 1286 
et al., 2019a). Debundling is then followed by nuclear import of the vRNPs into the nucleus. 1287 
MTOC, microtubule organising centre. The figure was adopted from (Banerjee et al., 2014)[MCK40]. 1288 
 1289 
Figure 3 1290 
Different classes of histone deacetylases (HDACs) and their domain composition. HDACs family 1291 
contains 18 isoforms, which can be categorized into four classes: class I (HDACs 1, 2, 3, and 8), 1292 
class II (HDACs 4, 5, 6, 7, 9 and 10) and class IV (HDAC11) HDACs are Zn2+ dependent 1293 
metalloproteases, and are mechanistically distinct from the NAD+ dependent class III HDACs 1294 
called SIRT ((Sirtuins) 1–7)(not shown). MEF, myocyte-specific enhancer factor 2A; SE14, Ser-1295 
Glu-containing tetradecapeptide repeats. Modified from (Ellmeier and Seiser, 2018). 1296 
 1297 
Figure 4 1298 
Domains of HDAC6 and their major functions. HDAC6 has tandem catalytic domains (CD1, CD2) 1299 
with the capacity to deacetylate tubulin and the presence of a zinc finger domain with that has 1300 
homology to ubiquitin-specific proteases (ZnF-UBP), which and  binds unanchored ubiquitin. 1301 
Binding to ubiquitin occurs by recognition of the C-terminal diglycine motif in unattached chains 1302 
or monoubiquitin. DDX3X, DEAD box RNA helicase 3, X-linked. Three-dimensional structure 1303 
data: HDAC6 (PDB ID: 5G0J). 1304 
 1305 
Figure 5 1306 
How HDAC6 reacts to cellular stress and virus entry. (Top panel) Cellular stress: misfolded 1307 
protein aggregates are poly-ubiquitinated, after which they are deubiquitinated by DUBs (not 1308 
shown), generating unanchored ubiquitin chains. The C-terminal-free ubiquitin is recognised by 1309 
HDAC6 ZnF-UBP and activates HDAC6 binding to dynein. The protein aggregate undergoes 1310 
retrograde transport on microtubules towards the MTOC, generating an aggresome. (Bottom 1311 
panel) Virus entry: IAV packages unanchored ubiquitin chains that are exposed to the cytosol 1312 
after low pH-mediated viral fusion at LEs. HDAC6 binds both to the unanchored chains and to 1313 
M1, forming an M1-HDAC6-polyubiquitin chain complex. HDAC6 activation and binding to 1314 
dynein and myosin II generates the shearing force needed to uncoat the M1 shell. 1315 
 1316 
Figure 6 1317 
A rendered structured illumination microscopy (SIM) [MCK41]image of individual IAV X31 1318 
particles stained against for HA (red) and unanchored ubiquitin (green). Scale bar; 100 nm. 1319 
 1320 
Figure 7 1321 
Domain composition of kKapβ2/TNPO1. Kapβ2 is a superhelical stacking of 20 HEAT repeats 1322 
(H1-H20). The RanGTP-binding domain locates at the N-terminal HEAT repeats 1-7. The H8 1323 
loop (residues 312-374) is crucial for substrate dissociation in the presence of Ran. HEAT repeats 1324 
9-20 comprise the substrate binding sites (adapted from (Lee et al., 2006, Twyffels et al., 1325 
2014))(Yoshizawa et al., 2018, Miyake et al., 2019a, Fernandez et al., 2019, Saito et al., 2019, 1326 
Hofweber et al., 2018). Three-dimensional structure data: kKapβ2 (PDB ID: 5YVG). 1327 
 1328 
Figure 8 1329 
Sequence alignment of known PY-NLSs with the conserved IAV M1 N-terminal sequence and 1330 
the HIV-1 CA. Sequences for epitopes 1 (a hydrophobic patch, containing glycine (highlighted in 1331 
light pink), 2 (a basic patch) and 3 (PY) were adapted from (Lee et al., 2006, Soniat and Chook, 1332 
2016). FUS, fused in sarcoma. Adapted from (Fernandez et al., 2019, Miyake et al., 2019b) 1333 
 1334 
Figure 9 1335 
HDAC6 and kKapβ2 are at the interface of cellular condensates and involved in regulation of 1336 
stress granules, protein aggregates and liquid-liquid phase separation (LLPS). Cellular condensates: 1337 
intrinsically disordered regions (IDRs) are acetylated upon cellular stress, and acetylated lysines 1338 
are subsequently deacetylated by HDAC6. Positively charged lysine residues in the IDR promotes 1339 
LLPS and allows other IDR-containing proteins as interaction partners of IDR to engage in the 1340 
formation of large mature SGs (Saito et al., 2019). Kapβ2 can bind to PY-NLSs in disordered 1341 
regions of condensates and chaperone their disaggregation (Yoshizawa et al., 2018, Hofweber et 1342 
al., 2018). Aggresomes: HDAC6 recognizes unanchored ubiquitin chains generated from 1343 
deubiquitination, such as by ataxin-3, of polyubiquitinated misfolded proteins, which binds to 1344 
HDAC6 and activates its interaction with the dynein motor. The misfolded proteins undergo 1345 
retrograde traffic on microtubules to form aggresomes.  1346 
 1347 
Figure 10[MCK42] 1348 
Model of stepwise IAV uncoating by HDAC6 and kKapβ2. (1)  Attachment to sialic acids on 1349 
receptor proteins on the cell surface triggers (2) virus uptake by clathrin-mediated endocytosis 1350 
(top) or macropinocytosis (bottom). (3) Endosome maturation, acidification and viral core priming 1351 
in endosomes via M2 induces conformational changes in the viral core. (4) Viral fusion at low pH 1352 
exposes ubiquitin chains to the cytosol recruiting HDAC6. (5) HDAC6 binding to ubiquitin chains 1353 
HDAC6 is recruited to the fusion pore, binds the ubiquitin chain thereby activatingactivate 1354 
dynein and myosin II interaction with HDAC6 (red arrows)s, . This generatinges a shearing force 1355 
that breaks apart the M1 shelluncoats the M1 shell and vRNP bundle release. Note that M1 1356 
uncoating and vRNP bundle release/debundling can take place on the LE cytosolic surface or in 1357 
the cytoplasm. In this scheme, vRNP release and debundling is shown in the cytoplasm for clarity 1358 
of representation. (6) Kapβ2 binds to PY-NLS on M1 (colored in red) and disaggregates the 1359 
vRNP-M1 bundle, leading to the debundling of vRNP debundlings into individual segments. (7) 1360 




Figure 11 1365 
PY-NLS is a viral cue that triggers IAV and HIV-1 uncoating. M1 dimers and CA hexamers are 1366 
the smallest unit of the viral shell. Recognition by Kapβ2 binds PY-NLSs viais dependent on the 1367 
hydrophobic side chains of substrate residues adjacent of G18 (IAV M1) or G89 (HIV-1 1368 
CA)[MCK43] on the capsid surface and promotes their disaggregation. The cue for Low pH is the 1369 
cue for PY-NLS exposure of IAV M1 is low pH exposure in endosomes, whereas  the cue for HIV-1370 
1 is unclear (Rose et al., 2018, Fernandez et al., 2019, Miyake et al., 2019b). Three-dimensional 1371 
structure data: M1 (PDB ID: 1EA3), CA (3J3Q), CA (3GV2), kapβ2 (5YVG). 1372 
